Wegovy pill sales smash forecasts after launch as Novo Nordisk hikes guidance

Novo Nordisk raised its outlook for 2026 after a strong performance from its newly launched Wegovy pill.

Leave a Reply

Your email address will not be published. Required fields are marked *